niacinamide has been researched along with Pheochromocytoma in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
Excerpt | Relevance | Reference |
---|---|---|
"Pheochromocytoma cells (clone PC-12) were treated with 6-aminonicotinamide." | 7.67 | Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide. ( Herken, H; Jung, W, 1989) |
"Pheochromocytoma cells (clone PC-12) were treated with 6-aminonicotinamide." | 3.67 | Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide. ( Herken, H; Jung, W, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denorme, M | 1 |
Yon, L | 1 |
Roux, C | 1 |
Gonzalez, BJ | 1 |
Baudin, E | 1 |
Anouar, Y | 1 |
Dubessy, C | 1 |
Maksimovic, O | 1 |
Schraml, C | 1 |
Hartmann, JT | 1 |
Bitzer, M | 1 |
Claussen, CD | 1 |
Pintoffl, J | 1 |
Horger, M | 1 |
Jung, W | 1 |
Herken, H | 1 |
Davis, LH | 1 |
Kauffman, FC | 1 |
4 other studies available for niacinamide and Pheochromocytoma
Article | Year |
---|---|
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Sur | 2014 |
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment.
Topics: Adrenal Gland Neoplasms; Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; | 2010 |
Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Alcohol Oxidoreductases; Animals; Biopterins; Chromatography, High Pressure Liq | 1989 |
Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Adrenal Gland Neoplasms; Animals; Carbon Dioxide; Cell Line; Gluconates; Glucos | 1987 |